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Abstract
In this study we investigated the effect of an ethanolic extract of propolis, with and
without CAPE, and some of its components on cyclooxygenase (COX) activity. Propolis
(0.00003–0.03%) significantly and concentration-dependently inhibited COX activity from
lung homogenate of saline- or LPS-treated rats. Same results were obtained with CAPE
(0.1–100 mM). COX activity from lung homogenate of saline- or LPS-treated rats was also
inhibited by galangin (0.1–100 mM), although the inhibition induced by the lowest
concentration was not significant. Caffeic, ferulic, cinnamic and chlorogenic acids and
pinocembrin, (0.1–100 mM) did not affect COX activity. The inhibition curves showed that
CAPE and propolis were equipotent inhibitors, whereas galangin was significantly (P-
0.001) less potent than propolis and CAPE. In order to better investigate the role of CAPE,
we tested the action of an ethanolic extract of propolis (0.00003–0.03%) without CAPE.
This extract significantly and concentration-dependently inhibited COX activity from lung
homogenate of saline- or LPS-treated rats, however, it resulted to be approximately 10 times
less potent than the extract containing CAPE. The analysis of the inhibition curves of the
extract with and without CAPE showed a significant (P-0.001) difference. These results
suggest that both CAPE and galangin contribute to the overall activity of propolis, CAPE
being more effective.
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1. Introduction
Propolis (bee glue) is a resinous dark-coloured material which is collected by
honeybees from the buds of living plants mixed with bee wax and salivary secretions.
Crude extracts of propolis have very complicated compositions, resulting from
variation in geographical and botanical origin w1x.
Propolis is well known for its medical effects, including anti-inflammatory, anti-
viral, immunostimulatory and carcinostatic activities w2x. The wide spectrum of
activity of propolis was mainly attributed to the large number of flavonoids w3x. In
addition to flavonoids, propolis contains cinnamic derivatives such as caffeic, ferulic,
cinnamic, chlorogenic acids and its esters w4x. Recently it has been reported that a
component of propolis, caffeic acid phenethyl ester (CAPE), exerts a potent anti-
inflammatory activity. The anti-inflammatory properties of CAPE have been attrib-
uted to suppression of prostaglandin (PG) and leukotriene synthesis w4x.
PG, which plays a central role in the inflammatory process, is generated from
arachidonic acid (AA) via the action of the enzyme cyclooxygenase (E.C. 1.14.991;
COX). Two isoforms of COX have been identified: the constitutive isoform (COX-
1), which seems to be almost ubiquitous and the inducible isoform (COX-2) which
is expressed by several cell types in response to inflammatory and immunological
stimuli w5x. Lung is a very rich source of PG mainly PGE and 6-keto-PGF . COX-2 1a
1 seems to be present in the whole lung homogenate of saline-treated rats, whereas
a time- and dose-dependent up-regulation of COX-2 seems to occur after LPS
challenge w6x.
In order to investigate the role of CAPE and other components in the overall
anti-inflammatory activity of propolis we investigated the effect of an ethanolic
extract of propolis, with and without CAPE, and some of its components on COX
activity from lung homogenate of saline- or LPS-treated rats, measured as PGE2
and 6-keto-PGF production from exogenously added AA.1a
2. Experimental
2.1. Drugs tested
The dried ethanol extract of propolis, with and without CAPE, was obtained from
Carlo Sessa, Milan, Italy. Total flavonoid content of propolis with CAPE, expressed
as galangin, was 9.04%; CAPE content was 10.44%. Total acidity, expressed as
caffeic acid, was 13%. Total flavonoid content of propolis without CAPE, expressed
as galangin, was 8.5%. CAPE, caffeic, ferulic, cinnamic, chlorogenic acids and
galangin were obtained from Sigma-Aldrich, Milan, Italy. Pinocembrin was obtained
from Trimital, Milan, Italy.
Stock solutions of test compounds were prepared in ethanol, an equivalent amount
of ethanol was included in control samples.
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2.2. Materials
Arachidonic acid was obtained from SPIBIO, Paris, France. Bacterial lipopoly-
saccharide (LPS) and all other reagents and compounds used were obtained from
Sigma-Aldrich, Milan, Italy.
2.3. Animals
Male Wistar rats (200–250 g; Mario Negri Sud, Chieti, Italy) were housed in a
controlled environment and provided with standard rodent chow and water. Animal
care was in compliance with Italian regulations on protection of animals used for
experimental and other scientific purposes (D.M. 116192) as well as with the EEC
regulations O.J. of E.C.L 358y1 12y18y1986.
2.4. Assessment of COX activity
Animals were treated i.p. with 6 mgykg of LPS or saline (0.9% NaCl; 2 mlykg).
Six hours after LPS or saline injection rats were anaesthetised with CO , lungs were2
removed and homogenised at 4 8C in protease inhibitor buffer, in a ratio 5:1
(vyw). The protein concentration in the homogenates was measured by the Bradford
assay w7x, with bovine serum albumin (BSA) used as standard. Homogenates were
pre-incubated for 5 min in the absence (controls) or presence of test compounds
and subsequently incubated at 37 8C for 30 min in the presence of excess arachidonic
acid (1 mM). Test compounds were the following: propolis, with and without
CAPE, (0.00003–0.03%), CAPE, galangin, pinocembrin, caffeic, ferulic, cinnamic
and chlorogenic acids (0.1–100 mM). The concentrations of CAPE and galangin
(0.1–100 mM) were the same as in the extracts. The samples were boiled and
centrifuged at 10 000=g for 30 min. The amount of PGE and 6-keto-PGF in the2 1a
supernatants was measured by radioimmunoassay w8x. Inhibition of prostanoid
generation by test compounds is calculated as percentage of activity in the presence
of drugs vs. the activity in the control samples.
2.5. Statistics
Results are expressed as the mean for four experiments performed in triplicate.
Data fit was obtained using the sigmoidal dose–response equation (variable slope)
(GraphPad software). The IC and the 95% confidence intervals were calculated50
by GraphPad Instat program (GraphPad software). Inhibition curves were analysed
and compared with two-way analysis of variance (ANOVA). A P-value less than
0.05 was considered to be statistically significant.
3. Results
3.1. Inhibition of COX activity from lung homogenate of saline-treated rats
The ethanolic extract of propolis (0.00003–0.03%) significantly and concentra-
tion-dependently inhibited, at all the concentrations tested, both PGE and 6-keto-2
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PGF with an IC of 0.00062% (0.00024–0.00158%) and 0.00094% (0.00058–1a 50
0.00153%), respectively (Fig. 1).
Same results were obtained with CAPE (0.1–100 mM) which significantly and
concentration-dependently inhibited, at all the concentrations tested, prostanoid
generation (Fig. 1). The IC values for PGE and 6-keto-PGF were 3.3 mM50 2 1a
(1.6–6.8 mM) and 3.9 mM (1.6–9.8 mM), respectively.
The production of PGE and 6-keto-PGF was also significantly inhibited by2 1a
galangin (0.1–100 mM) but only from the concentration of 1 mM (Fig. 1). The
IC values were 22 mM (10–47 mM) for PGE and 25 mM (13–49 mM) for 6-50 2
keto-PGF .1a
The other compounds tested—pinocembrin, caffeic, chlorogenic, ferulic and
cinnamic acids—did not inhibit, at all, the concentrations tested (0.1–100 mM),
prostanoid generation (data not shown).
In order to better investigate a better investigation, the role of CAPE in the
inhibition of PG biosynthesis by propolis we tested the action of an ethanolic extract
of propolis without CAPE. This extract (0.00003–0.03%) was approximately 10
times less potent than the extract containing CAPE since the inhibition of PGE2
and 6-keto-PGF production was significant only from the concentration of 0.0003%1a
(Fig. 1). The IC values were 0.0053% (0.0020–0.0140%) for PGE and 0.0072%50 2
(0.0017–0.0306%) for 6-keto-PGF .1a
The comparison of the inhibition curves showed a significant difference (P-
0.001) between propolis with and without CAPE, whereas the inhibition curves of
propolis and CAPE were almost superimposable. When we compared the inhibition
curves of propolis and galangin we found a significant (P-0.001) difference. On
the contrary, the inhibition curve of propolis without CAPE was not statistically
different from the inhibition curve of galangin.
3.2. Inhibition of COX activity from lung homogenate of LPS-treated rats
The ethanolic extract of propolis (0.00003–0.03%) significantly and concentra-
tion-dependently inhibited, at all the concentrations tested, both PGE and 6-keto-2
PGF production with IC values of 0.00029% (0.00016–0.00053%) and 0.0012%1a 50
(0.0009–0.0017%), respectively (Fig. 2).
Same results were obtained with CAPE (0.1–100 mM) which significantly and
concentration-dependently inhibited, at all the concentrations tested, prostanoid
generation (Fig. 2). The IC values for PGE and 6-keto-PGF were 0.88 mM50 2 1a
(0.21–3.64 mM) and 4.7 mM (1.1–19.8 mM), respectively.
Galangin (0.1–100 mM) was also effective, but the inhibition was significant
only from the concentration of 1 mM (Fig. 2). The IC values were 29 mM (13–50
66 mM) for PGE and 45 mM (26–77 mM) for 6-keto-PGF .2 1a
The other compounds tested—pinocembrin, caffeic, chlorogenic, ferulic and
cinnamic acids—did not inhibit, at all the concentrations tested (0.1–100 mM),
prostanoid generation (data not shown).
Next we tested the action of an ethanolic extract of propolis without CAPE. This
extract (0.00003–0.03%) significantly and concentration-dependently inhibited
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Fig. 1. Inhibitory effect of an ethanolic extract of propolis with (j) and without (h) CAPE, CAPE (%)
and galangin () on PGE and 6-keto-PGF production by lung homogenates, from saline-treated rats,2 1a
exposed to arachidonic acid for 30 min. Lung homogenates were incubated for 5 min with test com-
pounds before the addition of arachidonic acid. The concentrations of propolis extracts are expressed as
log% (wyv), whereas the concentrations of CAPE and galangin are expressed as log M. Each point
represents the mean of four experiments performed in triplicate.
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Fig. 2. Inhibitory effect of an ethanolic extract of propolis with (j) and without (h) CAPE, CAPE (%)
and galangin () on PGE and 6-keto-PGF production by lung homogenates, from LPS-treated rats,2 1a
exposed to arachidonic acid for 30 min. Lung homogenates were incubated for 5 min with test com-
pounds before the addition of arachidonic acid. The concentrations of propolis extracts are expressed as
log% (wyv), whereas the concentrations of CAPE and galangin are expressed as log M. Each point
represents the mean of four experiments performed in triplicate.
S36 A. Rossi et al. / Fitoterapia 73 Suppl. 1 (2002) S30–S37
PGE and 6-keto-PGF production but only from the concentration of 0.0003%2 1a
(Fig. 2). The IC values were 0.0035% (0.0013–0.0099%) for PGE and 0.0099%50 2
(0.0053–0.0185%) for 6-keto-PGF .1a
The comparison of the inhibition curves showed a significant difference (P-
0.001) between propolis containing CAPE and propolis without CAPE. the inhibition
curves of propolis and CAPE were almost superimposable, on the contrary the
inhibition curves of propolis and galangin were significantly (P-0.001) different,
whereas the inhibition curve of propolis without CAPE was not statistically different
from the inhibition curve of galangin.
4. Discussion
The anti-inflammatory activity of propolis is well known although the exact
mechanism of action and the compounds mainly responsible of this action are still
under debate. Research has been mainly focused on AA metabolism, since PG play
a central role in the inflammatory process w9x. Recently it has been reported that
CAPE, the caffeic acid phenethyl ester, which is present in the ethanolic extract of
propolis, inhibits AA metabolism in mouse peritoneal macrophages stimulated with
LPS or A23187 ionophore w4x. Moreover, CAPE seems to inhibit the activation by
tumour necrosis factor and other anti-inflammatory agents, such as phorbol ester,
ceramide, hydrogen peroxide and okadaic acid, of the transcription factor NF-kB
w10x which regulates the expression of many genes involved in inflammation w11x.
In this study we have studied the effect of an ethanolic extract of propolis, with
and without CAPE, and some of its components on COX activity from lung
homogenate of saline- and LPS-treated rats, measured as PG production from
exogenously added AA. Our results show that propolis concentration-dependently
inhibits COX activity from lung homogenate of saline- or LPS-treated rats. Among
the compounds tested only CAPE and galangin were active. However, the compar-
ison of the inhibition curves and the analysis of the IC indicate that, in our50
experimental model, CAPE is more potent than galangin. The central role of CAPE
is further supported by the evaluation of the effect of the extract of propolis without
CAPE. In fact this extract was a less potent (approx. 10 times) inhibitor of COX
activity when compared to the extract containing CAPE. The inhibitory activity of
the extract without CAPE seems to be due to the presence of galangin.
These results suggest that although both CAPE and galangin contribute to the
overall inhibitory activity of propolis, CAPE gives a greater contribution.
In our experimental model we could not detect, any selectivity of test compounds
towards the two isoforms of COX. Further studies using a more selective experi-
mental model are needed in order to better clarify this aspect.
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